New absorbable nerve cap aims to stop phantom pain after finger loss

NCT ID NCT06915662

Recruiting now Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a small absorbable cap placed over cut nerve endings during finger amputation surgery. The goal is to prevent painful neuromas (nerve balling) that often cause chronic pain. Twenty adults who have had a traumatic finger amputation will be followed for up to a year to see if the cap reduces pain and cold intolerance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tulavi Allay Nerve Cap (absorbable device placed over cut nerve ends)
What this could lead to: If successful, this could offer a simple way to prevent chronic nerve pain after finger amputation, reducing the need for additional surgeries.
What could go wrong: This is a small early-phase trial with only 20 people, so results may not apply broadly. The device is new and long-term safety is not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuralgia neuroma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROMA NEUROPATHIC PAIN

Contacts and locations

Locations

Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.